Methods: To address this, we have developed a protocol for transforming human primary hepatocytes into expandable Hepatocyte-Derived Liver Progenitor-Like Cells (HepLPCs).This study comprises a pre-clinical phase and an inaugural clinical trial involving nine cirrhosis patients to assess the feasibility and safety of HepLPC treatment.This investigator-initiated clinical study, generously funded by Shanghai Cryowise Technology Co., Ltd., marks a significant advancement in addressing the unmet medical needs of liver cirrhosis patients
for GOT, values were 21.5 (19.025.5) vs
Why Does GLP-1 Medication Cause Constipation
Gatchalian, program manager, interim co-director, Fralin Biomedical Research Institutes Addiction Recovery Research Center Anita S
Reddys Laboratories has already received permission from regulators to market generic semaglutide
This is generally a temporary issue that improves as your body adjusts